Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a ‘serious adverse event’ was reported in a participant in the UK, according to Stat News. 

Serious adverse events are suspected reactions to vaccines or drugs that require hospitalization, are life-threateningly or deadly. 

It’s unclear what the exact nature of the reaction was, but a person familiar with the matter told Stat News that the person is expected to recover. 

Trial holds are not uncommon, but it is a blow to worldwide hopes for a shot to be ready in the coming months, as the AstraZeneca shot was considered by many – including the World Health Organization – to be the leading candidate worldwide. 

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a 'serious adverse event' was reported in a participant in the UK

Phase 3 trials for the coronavirus vaccine being developed by Oxford University and AstraZeneca have been placed on a hold after a ‘serious adverse event’ was reported in a participant in the UK

LEAVE A REPLY

Please enter your comment!
Please enter your name here